IBDEI0SN ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13434,0)
 ;;=C22.2^^53^593^85
 ;;^UTILITY(U,$J,358.3,13434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13434,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,13434,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,13434,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,13435,0)
 ;;=D58.9^^53^593^87
 ;;^UTILITY(U,$J,358.3,13435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13435,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,13435,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,13435,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,13436,0)
 ;;=C81.99^^53^593^88
 ;;^UTILITY(U,$J,358.3,13436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13436,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,13436,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,13436,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,13437,0)
 ;;=C81.90^^53^593^89
 ;;^UTILITY(U,$J,358.3,13437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13437,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,13437,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,13437,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,13438,0)
 ;;=D89.2^^53^593^90
 ;;^UTILITY(U,$J,358.3,13438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13438,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,13438,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,13438,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,13439,0)
 ;;=D05.12^^53^593^91
 ;;^UTILITY(U,$J,358.3,13439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13439,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,13439,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,13439,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,13440,0)
 ;;=D05.11^^53^593^92
 ;;^UTILITY(U,$J,358.3,13440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13440,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,13440,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,13440,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,13441,0)
 ;;=D05.10^^53^593^93
 ;;^UTILITY(U,$J,358.3,13441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13441,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,13441,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,13441,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,13442,0)
 ;;=D50.0^^53^593^94
 ;;^UTILITY(U,$J,358.3,13442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13442,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,13442,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,13442,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,13443,0)
 ;;=D50.9^^53^593^95
 ;;^UTILITY(U,$J,358.3,13443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13443,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,13443,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,13443,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,13444,0)
 ;;=C46.9^^53^593^96
 ;;^UTILITY(U,$J,358.3,13444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13444,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,13444,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,13444,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,13445,0)
 ;;=C22.0^^53^593^97
 ;;^UTILITY(U,$J,358.3,13445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13445,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,13445,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,13445,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,13446,0)
 ;;=D05.02^^53^593^98
 ;;^UTILITY(U,$J,358.3,13446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13446,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,13446,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,13446,2)
 ;;=^5001928
